scholarly journals Erythromycin Estolate

2020 ◽  
Author(s):  
Keyword(s):  
Erythromycin Estolate

Hepatotoxicity to both erythromycin estolate and erythromycin ethylsuccinate

1982 ◽  
Vol 27 (8) ◽  
pp. 701-704 ◽  
Author(s):  
Emmet B. Keeffe ◽  
Thomas C. Reis ◽  
John E. Berland
Keyword(s):  
Erythromycin Estolate

Interaction Between Erythromycin and Theophylline

PEDIATRICS ◽  
1978 ◽  
Vol 61 (2) ◽  
pp. 324-325
Author(s):  
Miles Weinberger
Keyword(s):  
Macrolide Antibiotic ◽  
Clinical Importance ◽  
Hepatic Metabolism ◽  
Free Base ◽  
Theophylline Clearance ◽  
Additional Information ◽  
Erythromycin Estolate

The report of Cummins et al. (Pediatrics 59:144, January 1977) is of potential clinical importance. Additional information, however, would make their data easier to interpret. Erythromycin is marketed as the free base and as various salts. Only erythromycin estolate has been demonstrated to have hepatotoxic potential. Since troleandomycin, another macrolide antibiotic with even greater hepatotoxic potential, has a profound effect on theophylline clearance, probably by decreasing hepatic metabolism,1 the highest index of suspicion for a similar interaction with an erythromycin would be directed at the potentially hepatotoxic estolate salt (Ilosone).

Sign in / Sign up

Export Citation Format

Share Document